Immunoglobulin M, A, and G antibody response to lipopolysaccharide O antigen in symptomatic and asymptomatic Shigella infections
about
Epidemiology of pathogenic enterobacteria in humans, livestock, and peridomestic rodents in rural Madagascar.Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoidSafety and immunogenicity of improved Shigella O-specific polysaccharide-protein conjugate vaccines in adults in Israel.Safety and immunogenicity of two different lots of the oral, killed enterotoxigenic escherichia coli-cholera toxin B subunit vaccine in Israeli young adultsCommunity-based safety, immunogenicity, and transmissibility study of the Shigella sonnei WRSS1 vaccine in Israeli volunteersAntigen-specific IgA B memory cell responses to Shigella antigens elicited in volunteers immunized with live attenuated Shigella flexneri 2a oral vaccine candidates.A cohort study to define the age-specific incidence and risk factors of Shigella diarrhoeal infections in Vietnamese children: a study protocol.Serum antibody to lipopolysaccharide antigens of Shigella species among U.S. military personnel deployed to Saudi Arabia and Kuwait during Operations Desert Shield and Desert Storm.Detection of antibodies to Shigella lipopolysaccharide in urine after natural Shigella infection or vaccination.Recognition of three epitopic regions on invasion plasmid antigen C by immune sera of rhesus monkeys infected with Shigella flexneri 2a.Immune response to Shigella sonnei in U.S. MarinesSafety and immunogenicity of investigational Shigella conjugate vaccines in Israeli volunteers.Production of a Shigella sonnei Vaccine Based on Generalized Modules for Membrane Antigens (GMMA), 1790GAHBThe transfer and decay of maternal antibody against Shigella sonnei in a longitudinal cohort of Vietnamese infants.Immune response against lipopolysaccharide and invasion plasmid-coded antigens of shigellae in Vietnamese and Swedish dysenteric patients.Establishment of a Shigella sonnei human challenge model in Thailand.Clinical Trial of an Oral Live Shigella sonnei Vaccine Candidate, WRSS1, in Thai Adults.Antigen-specific B memory cell responses to lipopolysaccharide (LPS) and invasion plasmid antigen (Ipa) B elicited in volunteers vaccinated with live-attenuated Shigella flexneri 2a vaccine candidatesPresence of specific immunoglobulin A-secreting cells in peripheral blood after natural infection with Shigella sonneiEvidence for long-term memory of the mucosal immune system: milk secretory immunoglobulin A against Shigella lipopolysaccharidesFunctional and Antigen-Specific Serum Antibody Levels as Correlates of Protection against Shigellosis in a Controlled Human Challenge Study.In silico analysis to identify vaccine candidates common to multiple serotypes of Shigella and evaluation of their immunogenicity.Safety Profile and Immunologic Responses of a Novel Vaccine Against Shigella sonnei Administered Intramuscularly, Intradermally and Intranasally: Results From Two Parallel Randomized Phase 1 Clinical Studies in Healthy Adult Volunteers in Europe.Thymic independence of adaptive immunity to the intracellular pathogen Shigella flexneri serotype 2aImmunoglobulin subclass distribution and dynamics of Shigella-specific antibody responses in serum and stool samples in shigellosisHuman immune responses against Shigella and enterotoxigenic E. coli: Current advances and the path forward.Prospective study of the association between serum antibodies to lipopolysaccharide O antigen and the attack rate of shigellosis.Highlights of the 8th International Conference on Vaccines for Enteric Diseases: the Scottish Encounter To Defeat Diarrheal DiseasesAgglutinating secretory IgA preserves intestinal epithelial cell integrity during apical infection by Shigella flexneri.Socioeconomic correlates of antibody levels to enteric pathogens among Israeli adolescents.A Phase 2a Randomized Study to Evaluate the Safety and Immunogenicity of the 1790GAHB Generalized Modules for Membrane Antigen Vaccine against Shigella sonnei Administered Intramuscularly to Adults from a Shigellosis-Endemic Country.A Novel Proteome Microarray Discriminates Targets of Human Antibody Reactivity following Oral Vaccination and Experimental Challenge
P2860
Q31169585-9F1F66BB-030D-4BAF-B94F-AB42F35A9E1FQ33607442-48003B4E-F7A3-4957-9ADA-855930659F72Q34006223-B78372BD-306C-4FBE-831C-464DEF822E97Q34007642-6FB3A764-F75D-41E2-A70D-1E8F070C1FFCQ34194587-13B1109C-D381-42C7-A7DA-40B5D4EB9FFDQ34809879-5CF39551-6522-47E8-8CF9-AA2B5D981051Q34992202-F7464ECD-953C-45D7-92C5-0147175444D5Q35225017-04B68CE0-3F1B-4C44-BE21-59EC30FE6F34Q35227169-8E7B18B3-3221-46A4-BCDE-E29BAF190B70Q35443019-0B8B3339-1F79-4AE5-8535-169DB00BB375Q35521181-D2699DD6-BC42-4847-81F8-17655AC43752Q35523144-EFD91CCB-1B55-46AE-AA03-E2DE0B979581Q35924773-73CE05BD-0BF4-4962-8BB7-38A282683C78Q36547740-65F0E51E-FDBB-4421-91FA-9178661EACE0Q37064863-7788E8A6-9CC0-4C0C-94AD-C252520195BEQ37066116-690633EE-14C3-4068-9439-AA9EB6DD7B76Q37067290-0718ED4B-7317-4952-AD5A-C0DC7EFD51A8Q37120727-108276D5-2D96-4F84-9DE0-B20F037706C1Q37125747-E45A0ECD-A3B6-4910-AD47-8AF5BAF2D57FQ37245398-6FCDDFF8-C036-4FA2-B0D2-C4EE0AC3F008Q37633069-46B1F63B-D447-4FFF-AC8A-5D59672D6B7EQ38648043-F3272E38-3B94-4B05-B1E5-E701976A6628Q38665950-713D7936-D198-4A30-930B-8C7B149CA580Q39511268-F69A89DF-3229-4C30-B3C0-750C6FB73BD8Q39822100-58C0AA7C-2263-4803-A7E1-D8F56F95B9BAQ40192692-F2C05962-C1D7-49AD-B063-328B318D89EBQ40211202-06B9D521-C29D-47E5-97EB-C96D532B2381Q42554197-C1B5E633-DBB6-4808-87C8-C95876F5DE40Q43080002-47A5A349-F745-44D8-AF17-04748B319F3FQ44028556-65231585-BE05-42C8-B11B-B66311A68D3DQ49210830-AC8F94AB-05D0-4CC1-82CA-54A3084EE042Q57929967-9D334202-6B90-4F68-BF4B-E4C99046352E
P2860
Immunoglobulin M, A, and G antibody response to lipopolysaccharide O antigen in symptomatic and asymptomatic Shigella infections
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 1989
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immunoglobulin M, A, and G ant ...... ymptomatic Shigella infections
@en
Immunoglobulin M, A, and G ant ...... mptomatic Shigella infections.
@nl
type
label
Immunoglobulin M, A, and G ant ...... ymptomatic Shigella infections
@en
Immunoglobulin M, A, and G ant ...... mptomatic Shigella infections.
@nl
prefLabel
Immunoglobulin M, A, and G ant ...... ymptomatic Shigella infections
@en
Immunoglobulin M, A, and G ant ...... mptomatic Shigella infections.
@nl
P2093
P2860
P1476
Immunoglobulin M, A, and G ant ...... ymptomatic Shigella infections
@en
P2093
P2860
P304
P407
P577
1989-01-01T00:00:00Z